Top Markets
Coin of the day
Clarity Pharmaceuticals Ltd Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd

CU6
Classement en actions #11920
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company,... Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Prix de l'action
$1.65
Capitalisation boursière
$617.04M
Changement (1 jour)
-6.57%
Changement (1 an)
-15.12%
Pays
AU
Échange Clarity Pharmaceuticals Ltd (CU6)

Catégorie

Historique des divisions d’actions pour Clarity Pharmaceuticals Ltd (CU6)
L’action Clarity Pharmaceuticals Ltd (symbole : CU6) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 31, 2026.
Une action CU6 achetée avant le Aug 31, 2026 équivaudrait aujourd’hui à 0 actions CU6.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
2 x4
IE
0 -
CN
0 -
CH
0 -
CH
0 -
CN